Kimberly C. Darlington, MD, PhD
Basic Science Fellow
Areas of Interest
Translational and outcomes research in IBD
About
General interest is in defining novel diagnostic and therapeutic approaches for IBD. A major focus is defining molecular signatures of patients with UC and CD and determining how these may be used inform rational use of available therapies. The goal of both the molecular and outcomes research is to further optimize and develop new treatments for patients with IBD.
-
Undergraduate
Duke University, Trinity College, Biology
-
Medical School
Duke University School of Medicine
-
Residency
Duke University Hospital, Internal Medicine
-
Fellowship
University of North Carolina at Chapel Hill
-
PhD in Pharmacology and Cancer Biology
Duke University